Skip to main content

Blog

Duchenne UK and PPMD Award $500,000 to Evaluate Safety, Tolerability of Muscle Progenitor Cells in Phase 1 Trial

...

Ohio to Begin Screening Newborns for Duchenne

...

PPMD Celebrates 30th Anniversary with Launch of PPMD Together Meeting Series in Cincinnati, Ohio

...

Edgewise Therapeutics Announces Positive Two-Year Topline Results from ARCH Study of EDG-5506

...

Duchenne Siblings Study Published: Assessing Early Diagnosis from the Perspective of Parents with Multiple Children Diagnosed with Duchenne

...

PPMD Launches First State-Specific Duchenne Advocacy Day in Illinois

...

60+ Experts Unite to Author Consensus Statement Championing Duchenne Newborn Screening

...

WATCH: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat) (Webinar Recording)

...

Fiscal Year 2024 Appropriations Package Signed Into Law, Including Critical Funding for Duchenne and Becker

...

ITF Therapeutics Shares Update on DUVYZAT™ Following FDA Approval

...